General Information
|
|
Product
|
CD39 Peptide
|
Description
|
Antigenic Blocking Peptide EctoNucleoside TriPhosphate Diphosphohydrolase 1
|
Verified Applications
|
Immunodepletion, Immunocompetition
|
Peptide Description
|
Synthetic peptide taken within amino acid region 440-490 on human EctoNucleoside TriPhosphate Diphosphohydrolase 1.
|
Physical Properties
|
|
Quantity
|
250 µg
|
Volume
|
100 µl
|
Form
|
Antigenic Blocking Peptide
|
Storage
|
-20⁰C for long term storage
|
Application Protocol
|
Competition/Depletion assay
|
Refer to competition assay protocol
|
Protein
|
Uniprot #
|
P49961
|
Overview
|
In the nervous system, could hydrolyze ATP and other nucleotides to regulate purinergic neurotransmission. Could also be implicated in the prevention of platelet aggregation by hydrolyzing platelet-activating ADP to AMP.
|
Molecular Function
|
blood coagulation
cell adhesion
nucleobase-containing small molecule catabolic process
|
Subcellular Location
|
Membrane; Multi-pass membrane protein
|
Expression
|
Expressed primarily on activated lymphoid cells. Also expressed in endothelial tissues. Isoform 1 and isoform 3 are present in both placenta and umbilical vein, whereas isoform 2 is present in placenta only.
|
Structure
|
Belongs to the GDA1/CD39 NTPase family.
|
Alternative Nomenclature
|
ATPDase antibody
CD 39 antibody
CD39 antigen antibody
Ecto apyrase antibody
Ecto ATP diphosphohydrolase antibody
Ecto-ATPase 1 antibody
Ecto-ATPDase 1 antibody
Ectonucleoside triphosphate diphosphohydrolase 1 antibody
ENTPD1 antibody
Lymphoid cell activation antigen antibody
NTPDase 1 antibody
SPG64 antibody
|
|
|